Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses

被引:60
|
作者
Chuck, Chi-Pang [1 ]
Chow, Hak-Fun [2 ]
Wan, David Chi-Cheong [3 ]
Wong, Kam-Bo [1 ]
机构
[1] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China
来源
PLOS ONE | 2011年 / 6卷 / 11期
关键词
RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; IDENTIFICATION; VIRUSES; PROTEINASE; INHIBITOR; GENOME; RATES; HKU1;
D O I
10.1371/journal.pone.0027228
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Coronaviruses (CoVs) can be classified into alphacoronavirus (group 1), betacoronavirus (group 2), and gammacoronavirus (group 3) based on diversity of the protein sequences. Their 3C-like protease (3CL(pro)), which catalyzes the proteolytic processing of the polyproteins for viral replication, is a potential target for anti-coronaviral infection. Methodology/Principal Findings: Here, we profiled the substrate specificities of 3CL(pro) from human CoV NL63 (group 1), human CoV OC43 (group 2a), severe acute respiratory syndrome coronavirus (SARS-CoV) (group 2b) and infectious bronchitis virus (IBV) (group 3), by measuring their activity against a substrate library of 1968 of variants with single substitutions at P5 to P3' positions. The results were correlated with structural properties like side chain volume, hydrophobicity, and secondary structure propensities of substituting residues. All 3CL(pro) prefer Gln at P1 position, Leu at P2 position, basic residues at P3 position, small hydrophobic residues at P4 position, and small residues at P1' and P2' positions. Despite 3CL(pro) from different groups of CoVs share many similarities in substrate specificities, differences in substrate specificities were observed at P4 positions, with IBV 3CL(pro) prefers P4-Pro and SARS-CoV 3CL(pro) prefers P4-Val. By combining the most favorable residues at P3 to P5 positions, we identified super-active substrate sequences 'VARLQ down arrow SGF' that can be cleaved efficiently by all 3CL(pro) with relative activity of 1.7 to 3.2, and 'VPRLQ down arrow SGF' that can be cleaved specifically by IBV 3CL(pro) with relative activity of 4.3. Conclusions/Significance: The comprehensive substrate specificities of 3CL(pro) from each of the group 1, 2a, 2b, and 3 CoVs have been profiled in this study, which may provide insights into a rational design of broad-spectrum peptidomimetic inhibitors targeting the proteases.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
    Chiou, Wei-Chung
    Hsu, Meng-Shiuan
    Chen, Yun-Ti
    Yang, Jinn-Moon
    Tsay, Yeou-Guang
    Huang, Hsiu-Chen
    Huang, Cheng
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 147 - 153
  • [42] Functional dynamics of SARS-CoV-2 3C-like protease as a member of clan PA
    Kidera, Akinori
    Moritsugu, Kei
    Ekimoto, Toru
    Ikeguchi, Mitsunori
    BIOPHYSICAL REVIEWS, 2022, 14 (06) : 1473 - 1485
  • [43] Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
    Coppola, Nicola
    Pisaturo, Mariantonietta
    Tonziello, Gilda
    Sagnelli, Caterina
    Sagnelli, Evangelista
    Angelillo, Italo F.
    BMC INFECTIOUS DISEASES, 2012, 12
  • [44] Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
    Nicola Coppola
    Mariantonietta Pisaturo
    Gilda Tonziello
    Caterina Sagnelli
    Evangelista Sagnelli
    Italo F Angelillo
    BMC Infectious Diseases, 12
  • [45] Efficacy and tolerability of peginterferon α-2a and α-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis
    Coppola, N.
    Pisaturo, M.
    Sagnelli, C.
    Tonziello, G.
    Sagnelli, E.
    Angelillo, I. F.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S94 - S94
  • [46] High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2
    Smith, Emery
    Davis-Gardner, Meredith E.
    Garcia-Ordonez, Ruben D.
    Nguyen, Tu-Trinh
    Hull, Mitchell
    Chen, Emily
    Yu, Xuerong
    Bannister, Thomas D.
    Baillargeon, Pierre
    Scampavia, Louis
    Griffin, Patrick
    Farzan, Michael
    Spicer, Timothy P.
    SLAS DISCOVERY, 2023, 28 (03) : 95 - 101
  • [47] Functional dynamics of SARS-CoV-2 3C-like protease as a member of clan PA
    Akinori Kidera
    Kei Moritsugu
    Toru Ekimoto
    Mitsunori Ikeguchi
    Biophysical Reviews, 2022, 14 : 1473 - 1485
  • [48] Mappings preserving sum of products α1ab* + α2b*a + α3ba* (resp., α1ab* + α2b*a + α3a*b) on *-algebras
    Taghavi, Ali
    Ferreira, Jao Carlos da Motta
    Marietto, Maria das Gracas Bruno
    FILOMAT, 2023, 37 (09) : 2799 - 2806
  • [49] Characterization of Listeria monocytogenes serovar 1/2a, 1/2b, 1/2c and 4b by high resolution melting analysis for epidemiological investigations
    Tamburro, Manuela
    Sammarco, Michela Lucia
    Fanelli, Incoronata
    Ripabelli, Giancarlo
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2019, 310
  • [50] Interaction of Laurusides 1 and 2 with the 3C-like Protease (Mpro) from Wild-Type and Omicron Variant of SARS-CoV-2: A Molecular Dynamics Study
    Autiero, Ida
    Roviello, Giovanni N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)